152 related articles for article (PubMed ID: 37839515)
1. In-vitro and in-silico studies of annelated 1,4,7,8-tetrahydroazocine ester derivatives as nanomolar selective inhibitors of human butyrylcholinesterase.
de Candia M; Titov AA; Viayna A; Kulikova LN; Purgatorio R; Piergiovanni B; Niso M; Catto M; Voskressensky LG; Luque FJ; Altomare CD
Chem Biol Interact; 2023 Dec; 386():110741. PubMed ID: 37839515
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
3. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
4. Ester derivatives of annulated tetrahydroazocines: a new class of selective acetylcholinesterase inhibitors.
Carotti A; de Candia M; Catto M; Borisova TN; Varlamov AV; Méndez-Alvarez E; Soto-Otero R; Voskressensky LG; Altomare C
Bioorg Med Chem; 2006 Nov; 14(21):7205-12. PubMed ID: 16843666
[TBL] [Abstract][Full Text] [Related]
5. Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults.
Samarelli F; Purgatorio R; Lopopolo G; Deruvo C; Catto M; Andresini M; Carrieri A; Nicolotti O; De Palma A; Miniero DV; de Candia M; Altomare CD
Eur J Med Chem; 2024 Apr; 270():116353. PubMed ID: 38579622
[TBL] [Abstract][Full Text] [Related]
6. Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies.
Soliman AM; Abd El-Wahab HAA; Akincioglu H; Gülçin İ; Omar FA
Bioorg Chem; 2024 Jan; 142():106916. PubMed ID: 37913584
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of
Alcorn KN; Oberhauser IA; Politeski MD; Eckroat TJ
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2286935. PubMed ID: 38059272
[TBL] [Abstract][Full Text] [Related]
8. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A
Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751
[TBL] [Abstract][Full Text] [Related]
9. Identification of Compounds for Butyrylcholinesterase Inhibition.
Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M
SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114
[TBL] [Abstract][Full Text] [Related]
10. Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids - Design, synthesis, and biological evaluation.
Pidany F; Kroustkova J; Al Mamun A; Suchankova D; Brazzolotto X; Nachon F; Chantegreil F; Dolezal R; Pulkrabkova L; Muckova L; Hrabinova M; Finger V; Kufa M; Soukup O; Jun D; Jenco J; Kunes J; Novakova L; Korabecny J; Cahlikova L
Eur J Med Chem; 2023 Apr; 252():115301. PubMed ID: 36996715
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors.
Ma W; Bi J; Zhao C; Gao Y; Zhang G
Carbohydr Res; 2020 May; 491():107977. PubMed ID: 32169593
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
13. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer's disease.
Pourtaher H; Hasaninejad A; Iraji A
Sci Rep; 2022 Sep; 12(1):15236. PubMed ID: 36075926
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
Makhaeva GF; Boltneva NP; Lushchekina SV; Rudakova EV; Serebryakova OG; Kulikova LN; Beloglazkin AA; Borisov RS; Richardson RJ
Bioorg Med Chem; 2018 Sep; 26(16):4716-4725. PubMed ID: 30104121
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potent and Selective Acetylcholinesterase/Butyrylcholinesterase Inhibitors by Virtual Screening.
Xu T; Li S; Li AJ; Zhao J; Sakamuru S; Huang W; Xia M; Huang R
J Chem Inf Model; 2023 Apr; 63(8):2321-2330. PubMed ID: 37011147
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors.
Ghobadian R; Esfandyari R; Nadri H; Moradi A; Mahdavi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Edraki N; Sharifzadeh M; Amini M
Mol Divers; 2020 Feb; 24(1):211-223. PubMed ID: 30927138
[TBL] [Abstract][Full Text] [Related]
20. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
